Evidence map›Paper›PMID 30996252›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.

Hee Eun Lee, Muhammad Arshad, Rushin D Brahmbhatt, Tanya L Hoskin, Stacey J Winham, Marlene H Frost, Derek C Radisky, Lori A Denison, Amy C Degnim, Daniel W Visscher

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Molecular Trajectory ofFrontiers in oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hee Eun LeeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Muhammad ArshadDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Rushin D BrahmbhattDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Tanya L HoskinDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Stacey J WinhamDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-8492-9102
Marlene H FrostDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Derek C RadiskyDepartment of Cancer Biology, Mayo Clinic, Rochester, MN, USA.
Lori A DenisonDepartment of Information Technology, Mayo Clinic, Rochester, MN, USA.
Amy C DegnimDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-2303-4946
Daniel W VisscherDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Visscher.Daniel@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the histology and the frequency of a histologic entity that we term "hyaline fibrous involution", which is characterized by symmetric and regular deposition of basal lamina-like periacinar hyaline material in association with atrophic epithelium, in breast samples from patients with either benign breast disease or germline BRCA mutation. Women with germline BRCA mutation (n = 93) who underwent prophylactic mastectomy (BRCA group) were compared to an age-matched sample of women who underwent biopsy for benign breast disease (n = 93). Median age was 45 years (range, 25-72 years). A single H&E section of each subject's benign breast tissue was reviewed. The total number of terminal duct lobular units and the number of terminal duct lobular units with hyaline fibrous involution were recorded for each case. The presence of any hyaline fibrous involution lobules and the within-sample proportion of hyaline fibrous involution lobules relative to total lobules were compared between groups. Presence of any hyaline fibrous involution was significantly more frequent in the BRCA group compared to the benign breast disease group, 47% vs. 15% (p < 0.0001, adjusted for total lobules). In women with any hyaline fibrous involution lobules, these unusual lobules were similarly rare in both groups, with median proportion of hyaline fibrous involution-positive lobules relative to all lobules of 0.03 in BRCA specimens (n = 44) and 0.03 in the benign breast disease group (n = 14). Within the BRCA group, frequency of any hyaline fibrous involution present was significantly higher in the perimenopausal age group (45-55 years: 63%) compared to other age groups (<45 years, 44%; >55 years, 15%; p = 0.05 and p = 0.02, respectively). Increased presence of hyaline fibrous involution in the setting of BRCA mutation suggests that it may represent a pathologic entity, possibly reflecting abnormal involution or an abnormal response to DNA damage.

Indexed as

HyalinAdultAgedBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsFemaleGerm-Line MutationHumansMammary Glands, HumanMiddle AgedBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID30996252
OpenAlexW2936640051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.